acetazolamide

Generic: acetazolamide

Labeler: ani pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acetazolamide
Generic Name acetazolamide
Labeler ani pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

acetazolamide 125 mg/1

Manufacturer
ANI Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 70954-033
Product ID 70954-033_bf074cfc-87f3-4328-a251-65f3f9d8556e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210588
Listing Expiration 2027-12-31
Marketing Start 2019-10-17

Pharmacologic Class

Established (EPC)
carbonic anhydrase inhibitor [epc]
Mechanism of Action
carbonic anhydrase inhibitors [moa]
Chemical Structure
sulfonamides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70954033
Hyphenated Format 70954-033

Supplemental Identifiers

RxCUI
197303 197304
UPC
0370954033301 0370954034308
UNII
O3FX965V0I
NUI
N0000175517 N0000000235 M0020790

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acetazolamide (source: ndc)
Generic Name acetazolamide (source: ndc)
Application Number ANDA210588 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 125 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE (70954-033-20)
  • 100 TABLET in 1 BOTTLE (70954-033-30)
source: ndc

Packages (2)

70954-033-20 1000 TABLET in 1 BOTTLE (70954-033-20) 70954-033-30 100 TABLET in 1 BOTTLE (70954-033-30)

Ingredients (1)

acetazolamide (125 mg/1)

Linked Drug Pages (1)

Acetazolamide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "bf074cfc-87f3-4328-a251-65f3f9d8556e", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "upc": ["0370954033301", "0370954034308"], "unii": ["O3FX965V0I"], "rxcui": ["197303", "197304"], "spl_set_id": ["bde94a48-05d0-45a0-a589-ec05b7d16532"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (70954-033-20)", "package_ndc": "70954-033-20", "marketing_start_date": "20191017"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (70954-033-30)", "package_ndc": "70954-033-30", "marketing_start_date": "20191017"}], "brand_name": "Acetazolamide", "product_id": "70954-033_bf074cfc-87f3-4328-a251-65f3f9d8556e", "dosage_form": "TABLET", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "70954-033", "generic_name": "Acetazolamide", "labeler_name": "ANI Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acetazolamide", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "125 mg/1"}], "application_number": "ANDA210588", "marketing_category": "ANDA", "marketing_start_date": "20191017", "listing_expiration_date": "20271231"}